|
Magyar Nephrologiai Társaság |
|
32nd European Meeting on Hypertension and Cardiovascular Protection |
Rendezvény kezdete: 2023.06.23. | Rendezvény vége: 2023.06.26. |
Helyszín: Italy, Milan, |
A rendezvény Web oldala: https://esh2023.eu/ |
Following the successful experience of the ESH 2022 Hybrid meeting, ESH has decided once again to hold a hybrid meeting in 2023, accommodating the needs of international delegates, and at the same time, providing an onsite ESH congress experience for those who wish to attend in person. In times of uncertainty, taking this approach has proven to be very effective in catering to our international attendance. No matter your timezone, we welcome you to join us in yet another exciting annual meeting. |
|
|
 |
|
Magyar Dermatológiai Társulat |
|
ESDO - 11th European School of Dermato Oncology (hibrid, Berlin, 2023.01.13-14.) |
Rendezvény kezdete: 2023.01.13. | Rendezvény vége: 2023.01.14. |
Helyszín: Germany, 10623 Berlin, hibrid, Strasse des 17 Juni 106-108, Novotel Berlin am Tiergarten |
A rendezvény Web oldala: https://european-school-of-dermato-oncology.org/ |
EARLY BIRD REGISTRATION deadline: 2022.12.21. for only 190 Euros.
Registration fees >>
Online registration >>
Preliminary program >>
Dear colleagues and friends,
We have the great pleasure to invite you to join us for the 11th European School of Dermato Oncology in Berlin. The event place as an on-site meeting with additional virtual access from January 13 - 14, 2023.
The course consists of plenary sessions and interactive outbreak sessions. Plenary sessions will comprise clear structured and up-to-date presentations followed by audience discussion.
Voting devices will be used to respond to multiple choice questions. These questions may precede the presentation of the structured knowledge or may be presented at the end in order to test the level of knowledge the audience has gained.
The main part of the course consists of 6 interactive sessions, each with no more than 40 attendants. Every participant takes part in each of these sessions which mainly comprise casebased discussion. These will be used to illustrate treatment pathways, how risk and benefit are assessed, and how management decisions are made.
We look forward to welcoming you in Berlin in January 2023!
Claus Garbe, MD Axel Hauschild, MD Nicole Kelleners-Smeets, MD Ricardo Vieira, MD
Course Directors |
|
|
 |